W. Harry Feinstone Department of Molecular Microbiology and Immunology, Malaria Research Institute, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
W. Harry Feinstone Department of Molecular Microbiology and Immunology, Malaria Research Institute, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
mBio. 2017 Oct 17;8(5):e01631-17. doi: 10.1128/mBio.01631-17.
Malaria parasite ookinetes must traverse the vector mosquito midgut epithelium to transform into sporozoite-producing oocysts. The innate immune system is a key regulator of this process, thereby determining vector competence and disease transmission. The role of innate immunity factors as agonists or antagonists of malaria parasite infection has been previously determined using specific single - species combinations. Here we show that the two C-type lectins CTL4 and CTLMA2 exert differential agonistic and antagonistic regulation of parasite killing in African and South American species. The C-type lectins regulate both parasite melanization and lysis through independent mechanisms, and their implication in parasite melanization is dependent on infection intensity rather than mosquito-parasite species combination. We show that the leucine-rich repeat protein LRIM1 acts as an antagonist on the development of ookinetes and as a regulator of oocyst size and sporozoite production in the South American mosquito Our findings explain the rare observation of human melanization and define a key factor mediating the poor vector competence of for and Malaria, one of the world's deadliest diseases, is caused by parasites that are vectored to humans by the bite of mosquitoes. The mosquito's innate immune system is actively engaged in suppressing infection. Studies on mosquito immunity revealed multiple factors that act as either facilitators or inhibitors of infection, but these findings were mostly based on single - species combinations, not taking into account the diversity of mosquito and parasite species. We show that the functions of CTL4 and CTLMA2 have diverged in different vector species and can be both agonistic and antagonistic for infection. Their protection against parasite melanization in is dependent on infection intensity, rather than the mosquito-parasite combination. Importantly, we describe for the first time how LRIM1 plays an essential role in infection of , suggesting it is a key regulator of the poor vector competence of this species.
疟原虫的合子必须穿过媒介蚊子的中肠上皮细胞,才能转化为产生子孢子的卵囊。先天免疫系统是调节这一过程的关键,从而决定了媒介的感染力和疾病的传播。以前已经通过特定的单一物种组合确定了先天免疫因子作为疟原虫感染的激动剂或拮抗剂的作用。在这里,我们表明两种 C 型凝集素 CTL4 和 CTLMA2 在非洲和南美洲物种中对寄生虫杀伤表现出不同的激动和拮抗调节作用。C 型凝集素通过独立的机制调节寄生虫的黑化和裂解,其对寄生虫黑化的影响取决于感染强度,而不是蚊子-寄生虫的物种组合。我们表明富含亮氨酸的重复蛋白 LRIM1 作为一种拮抗剂作用于合子的发育,并调节南美洲蚊子卵囊的大小和子孢子的产生。我们的研究结果解释了人类黑化的罕见观察,并定义了一个关键因素,介导了 对 和 的不良媒介能力。
疟疾是由疟原虫引起的,疟原虫通过蚊子的叮咬传播给人类。蚊子的先天免疫系统积极参与抑制感染。对蚊子免疫的研究揭示了多种既可以作为寄生虫感染的促进剂也可以作为抑制剂的因子,但这些发现大多基于单一物种组合,没有考虑到蚊子和寄生虫物种的多样性。我们表明,CTL4 和 CTLMA2 的功能在不同的媒介物种中已经分化,并且对 感染既可以是激动剂也可以是拮抗剂。它们在 中对寄生虫黑化的保护作用依赖于感染强度,而不是蚊子-寄生虫的组合。重要的是,我们首次描述了 LRIM1 在 感染中的作用,这表明它是该物种不良媒介能力的关键调节剂。